Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Andrology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    June 2022
  1. STARITA N, Pezzuto F, Sarno S, Losito NS, et al
    Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients.
    Int J Cancer. 2022;150:1879-1888.
    PubMed     Abstract available


    May 2022
  2. WATTS EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, et al
    Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia.
    Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34116.
    PubMed     Abstract available


    April 2022
  3. XIU M, Zhang P, Wang X, Fan Y, et al
    Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant versus standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: a prospective cohort study with propensity-matched analysis.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34022.
    PubMed     Abstract available


    March 2022
  4. COUSIN S, Blay JY, Garcia IB, de Bono JS, et al
    Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study.
    Int J Cancer. 2022;150:993-1006.
    PubMed     Abstract available


  5. ZNAOR A, Skakkebaek NE, Meyts ER, Kulis T, et al
    Global patterns in testicular cancer incidence and mortality in 2020.
    Int J Cancer. 2022 Mar 12. doi: 10.1002/ijc.33999.
    PubMed     Abstract available


    October 2021
  6. SKOLD C, Koliadi A, Enblad G, Stalberg K, et al
    Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
    Int J Cancer. 2021 Oct 14. doi: 10.1002/ijc.33844.
    PubMed     Abstract available


  7. DICKEY BL, Fan W, Bettampadi D, Reich RR, et al
    Sequential acquisition of human papillomavirus infection between genital and oral anatomic sites in males.
    Int J Cancer. 2021;149:1483-1494.
    PubMed     Abstract available


    September 2021
  8. LIU W, Liu Y, Hu C, Xu C, et al
    Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells.
    Int J Cancer. 2021;149:1369-1384.
    PubMed     Abstract available


    July 2021
  9. LIU C, Huang B, Wu R, Chen J, et al
    Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.
    Int J Cancer. 2021;149:158-168.
    PubMed     Abstract available


    June 2021
  10. PAVONE R, Pacquement H, Pasquet M, Sudour-Bonnange H, et al
    Childhood ovarian non-seminomatous germ cell tumors: A Highly Curable Disease With Few Long-Term Treatment-Related Toxicities. Results of the French TGM95 study.
    Int J Cancer. 2021 Jun 19. doi: 10.1002/ijc.33710.
    PubMed     Abstract available


    March 2021
  11. WATTS EL, Perez-Cornago A, Knuppel A, Tsilidis KK, et al
    Prospective analyses of testosterone and SHBG with risk of 19 types of cancer in men and postmenopausal women in UK Biobank.
    Int J Cancer. 2021 Mar 15. doi: 10.1002/ijc.33555.
    PubMed     Abstract available


  12. GU W, Wan F, Chen J, Gan H, et al
    Identification of a methylation panel aid in risk stratification in node-positive penile squamous cell carcinoma.
    Int J Cancer. 2021;148:1289-1298.
    PubMed     Abstract available


    February 2021
  13. ARTHUR RS, Dannenberg AJ, Rohan TE
    The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and SHBG with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
    Int J Cancer. 2021 Feb 10. doi: 10.1002/ijc.33508.
    PubMed     Abstract available


    December 2020
  14. ROUTH JC, Dasgupta R, Chi YY, Shnorhavorian M, et al
    Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Int J Cancer. 2020;147:3168-3176.
    PubMed     Abstract available


    November 2020
  15. WATTS EL, Fensom GK, Smith Byrne K, Perez-Cornago A, et al
    Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200,000 men in UK Biobank.
    Int J Cancer. 2020 Nov 30. doi: 10.1002/ijc.33416.
    PubMed     Abstract available


    May 2020
  16. STANG A, Wellmann I, Kajuter H, Trocchi P, et al
    Differences in site-specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007-2015.
    Int J Cancer. 2020 May 23. doi: 10.1002/ijc.33109.
    PubMed     Abstract available


    April 2020
  17. JIANG YT, Gong TT, Zhang JY, Li XQ, et al
    Infertility and ovarian cancer risk: evidence from nine prospective cohort studies.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33012.
    PubMed     Abstract available


  18. IDAHL A, Cornet CL, Maldonado SG, Waterboer T, et al
    Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
    Int J Cancer. 2020 Apr 3. doi: 10.1002/ijc.32999.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: